BIOMARKER:

IDH1 mutation + Chr del(1p) + Chr del(19q)

A2 | Sensitive

C3 | Sensitive

D | Sensitive

A2 | Resistant

C3 | Resistant

D | Resistant

Oligodendroglioma

Glioma

temozolomide

IDH1 mutation + Chr del(1p) + Chr del(19q)|Oligodendroglioma|temozolomide

cisplatin

IDH1 mutation + Chr del(1p) + Chr del(19q)|Oligodendroglioma|cisplatin

carboplatin

IDH1 mutation + Chr del(1p) + Chr del(19q)|Oligodendroglioma|carboplatin

etoposide IV

IDH1 mutation + Chr del(1p) + Chr del(19q)|Oligodendroglioma|etoposide IV

bevacizumab

IDH1 mutation + Chr del(1p) + Chr del(19q)|Oligodendroglioma|bevacizumab

carmustine

IDH1 mutation + Chr del(1p) + Chr del(19q)|Oligodendroglioma|carmustine

lomustine

IDH1 mutation + Chr del(1p) + Chr del(19q)|Oligodendroglioma|lomustine

PCV

IDH1 mutation + Chr del(1p) + Chr del(19q)|Oligodendroglioma|PCV

nivolumab

IDH1 mutation + Chr del(1p) + Chr del(19q)|Glioma|nivolumab

decitabine

IDH1 mutation + Chr del(1p) + Chr del(19q)|Glioma|decitabine